Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Moderator: Johann Sellner (Mistelbach, Austria) Guest: Tamuna Akhvlediani (Tbilisi, Georgia) In this podcast episode, Prof. Johann Sellner interviews Prof. Tamuna Akhvlediani about the neurological aspects of new antiviral drugs for SARS-CoV-2. They discuss drugs like monoclonal antibodies, paxlovid, and remdesivir, emphasizing their mechanisms and potential applications beyond COVID-19. Prof. Akhvlediani details neurological side effects observed in trials and significant drug interactions, especially in chronic neurological patients. The episode closes with insights into managing these interactions in clinical practice.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(216)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
ufo-sverige
kapitalet-en-podd-om-ekonomi
medicinvetarna
halsorevolutionen
sexet
rss-ufobortom-rimligt-tvivel
rss-vetenskapsradion
ufo-sverige-2
dumforklarat
det-morka-psyket
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
ideer-som-forandrar-varlden
rss-geopodden-2
vetenskapsradion
bildningspodden
svd-nyhetsartiklar